Inflammatory response in cardiac surgery: Concepts and evolving practices;Réponse inflammatoire en chirurgie cardiaque: Concepts et évolution des pratiques en circulation extracorporelle

Sang Thrombose Vaisseaux

Volumn 13, Issue 8-9, 2001, Pages 468-475

  Baufreton, C ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT;

BLOOD CLOTTING; CARDIOPULMONARY BYPASS; EXTRACORPOREAL CIRCULATION; HEART SURGERY; HEMOSTASIS; HUMAN; INFLAMMATION; MONOCYTE; MORBIDITY; NEUTROPHIL; ORGAN PERFUSION; PATHOPHYSIOLOGY; SHORT SURVEY; SPLANCHNIC BLOOD FLOW; SURGICAL APPROACH; SURGICAL MORTALITY; THROMBOCYTE;

EID: 0035658138     PISSN: 09997385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (46)

1. Why cardiopulmonary bypass makes patients sick: Strategies to control the blood-synthetic surface interface
2. Endothelial cell injury in cardiovascular surgery: The procoagulant response
3. Endothelial cell injury in cardiovascular surgery: The systemic inflammatory response
4. Inflammatory response to cardiopulmonary bypass using two different types of heparin-coated extracorporeal circuits
5. Inflammatory response to cardiopulmonary bypass using roller or centrifugal pumps
6. Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by tumor necrosis factor
7. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization
8. Cytokine response to cardiopulmonary bypass: Lessons learned from cardiac transplantation
9. Heparin coating of extracorporeal circuits inhibits contact activation
10. Biomaterials in cardiopulmonary bypass
11. Les traitements de surface en circulation extracorporelle
12. Low heparinization with heparinbonded bypass circuits: Is it a safe strategy?
13. Clinical evaluation of Duraflo® II heparin-treated extracorporeal circulation circuits (2nd version). The European working group of heparin-coated extracorporeal circulation circuits
14. Heparin coating with aprotinin reduces blood activation during coronary artery operations
15. Heparin-coated circuits for high-risk patients: A multicenter, prospective, randomized trial
16. Heparin coated circuits and aprotinin prime for coronary artery bypass grafting
17. Activation of the complement system during and after cardiopulmonary bypasssurgery: Postsurgery activation involves C-reactive protein and is associatedwith postoperative arrhythmia
18. Clinical outcome after coronary sugery with heparin-coated extracorporeal circuits for cardiopulmonary bypass
19. Decreased incidence of arterial thrombosis using heparin-bonded intraaortic balloons
20. Material and circuit related bioincompatibility of cardiopulmonary bypass in cardiovascular surgery
21. Haemolysis during cardiopulmonary bypass: An in vivo comparison of standard roller pumps, nonocclusive roller pumps and centrifugal pumps
22. Systemic blood activation with open and closed venous reservoirs
23. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass
24. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass
25. Procoagulant activity after off-pump coronary operation: Is the current anticoagulation adequate?
26. Complement activation in coronary artery bypass grafting patients without cardiopulmonary bypass: The role of tissue injury by surgical incision
27. Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis
28. Cardiopulmonary bypass with heparincoated circuits and reduced systemic anticoagulation
29. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparinbonded cardiopulmonary bypass circuits
30. Influence of different autotransfusion devices on the quality of salvaged blood
31. The effect of cardiotomy suction on the brain injury marker S100β after cardiopulmonary bypass
32. Reduction of heparin dose is not beneficial to platelet function
33. Synergism between zymosan-activated serum and heparin in the induction of polymorphonuclear leukocyte aggregation
34. Enhancement of the leukocyteendothelial cell interaction in collecting venules of skeletal muscle by protamine
35. Hypoxia, reoxygenation and the role of systemic leukodepletion in pediatric heart surgery
36. Normoxic cardiopulmonary bypass reduces oxydative myocardial damage and nitric oxide during cardiac operations in the adult
37. Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants
38. Leukodepletion and aprotinin improve clinical outcome after extracorporeal circulation
39. The effects of leucodepletion in patients who develop the systemic inflammatory response syndrome following cardiopulmonary bypass
40. Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability
41. Intestinal permeability, circulating endotoxin, and postoperative systemicresponses in cardiac surgery patients
42. A clinical study on the effects of pulsatile cardiopulmonary bypass on the blood endotoxin levels
43. Perfusion-related factors of endotoxin release during cardiopulmonary bypass
44. Computation of haemodynamic power and input impedance in the ascending aorta of patients undergoing open heart surgery
45. Reduction in prime volume attenuates the hyperdynamic response after cardiopulmonary bypass
46. Multiple sequential insults cause post-pump syndrome